Company research
Oncternal Therapeutics, Inc.
CIK 1260990Updated Sep 27, 2026
Name history
GTX INC /DE/ · through Jun 11, 2019GTX INC/TN · through Jan 15, 2004
Filing activity
Latest filing
50 filings on record · EFFECT, 15-12G, S-8 POS, POS AM, 25, 8-K.
Recent filings
Show 5 more recent filings
Financials
FY 2023 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 36,729,000Source | 68,651,000Source | 93,585,000Source | 118,809,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 6,697,000Source | 37,142,000Source | 90,765,000Source | 116,737,000Source |
| Assets, CurrentUSD | 36,059,000Source | 67,290,000Source | 92,853,000Source | 118,003,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 1,804,000Source | 3,566,000Source | 2,088,000Source | — |
| Operating Lease, Right-of-Use AssetUSD | 258,000Source | 87,000Source | 75,000Source | 40,000Source |
| Other Assets, NoncurrentUSD | 412,000Source | 1,274,000Source | 657,000Source | 766,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 6,677,000Source | — | — | — |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | — | — |
| Common Stock, Value, IssuedUSD | 3,000Source | 57,000Source | 49,000Source | 49,000Source |
| Additional Paid in CapitalUSD | 227,825,000Source | 219,203,000Source | 202,201,000Source | 195,699,000Source |
| Retained Earnings (Accumulated Deficit)USD | -197,779,000Source | -158,300,000Source | -114,130,000Source | -82,797,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 3,000Source | 9,000Source | — | — |
| Stockholders' Equity Attributable to ParentUSD | 30,052,000Source | 60,969,000Source | 88,120,000Source | 112,951,000Source |
| Liabilities and EquityUSD | 36,729,000Source | 68,651,000Source | 93,585,000Source | 118,809,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 5,198,000Source | 7,682,000Source | 5,465,000Source | 5,858,000Source |
| Operating Lease, Liability, CurrentUSD | 173,000Source | 87,000Source | 75,000Source | 40,000Source |
| Accounts Payable, CurrentUSD | 1,148,000Source | 2,917,000Source | 1,959,000Source | 1,143,000Source |
| Operating Lease, Liability, NoncurrentUSD | 145,000Source | — | — | — |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 3,877,000Source | 4,678,000Source | 3,431,000Source | 3,042,000Source |
| Short-term InvestmentsUSD | 27,558,000Source | 26,582,000Source | — | — |
cash flow · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -39,479,000Source | -44,170,000Source | -31,333,000Source | -17,225,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 7,500,000Source | 7,431,000Source | 5,875,000Source | 1,556,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts PayableUSD | -1,769,000Source | 958,000Source | 816,000Source | 272,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -32,164,000Source | -36,704,000Source | -26,589,000Source | -17,495,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 651,000Source | -26,498,000Source | — | — |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 156,000Source | 3,000Source | — | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 1,068,000Source | 9,579,000Source | 617,000Source | 114,181,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -30,445,000Source | -53,623,000Source | -25,972,000Source | 96,686,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 7,500,000Source | 7,431,000Source | 5,875,000Source | 1,556,000Source |
| General and Administrative ExpenseUSD | 12,746,000Source | 13,457,000Source | 11,595,000Source | 8,373,000Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | — | — |
| Investment Income, InterestUSD | 2,235,000Source | 777,000Source | 33,000Source | 16,000Source |
| Net Income (Loss) Attributable to ParentUSD | -39,479,000Source | -44,170,000Source | -31,333,000Source | -17,225,000Source |
| Operating ExpensesUSD | 42,499,000Source | 46,437,000Source | 35,681,000Source | 20,917,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 33,000Source | 317,000Source |
| Proceeds from Issuance of Common StockUSD | 1,224,000Source | 9,582,000Source | — | 113,876,000Source |
| Proceeds from Issuance of Long-term DebtUSD | — | — | — | 301,000Source |
income statement · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Total RevenueUSD | 785,000Source | 1,490,000Source | 4,315,000Source | 3,375,000Source |
| Operating Income (Loss)USD | -41,714,000Source | -44,947,000Source | -31,366,000Source | -17,542,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 33,000Source | 317,000Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -39,479,000Source | -44,170,000Source | -31,333,000Source | -17,225,000Source |
| Earnings Per Share, BasicUSD per share | -13.43Source | -0.84Source | — | — |
| Earnings Per Share, DilutedUSD per share | -13.43Source | -0.84Source | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 2,940,000Source | 52,594,000Source | — | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 2,940,000Source | 52,594,000Source | — | — |
| Additional Financial Items | ||||
| General and Administrative ExpenseUSD | 12,746,000Source | 13,457,000Source | 11,595,000Source | 8,373,000Source |
| Investment Income, InterestUSD | 2,235,000Source | 777,000Source | 33,000Source | 16,000Source |
| Operating ExpensesUSD | 42,499,000Source | 46,437,000Source | 35,681,000Source | 20,917,000Source |
| Research and Development ExpenseUSD | — | 0Source | 0Source | 0Source |